All In Biotech

Drug Trial Radar · NCT05275400

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)

Last checked: Nov 20, 2026Latest source record: Jun 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 986 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

986

Actual

Start

Mar 8, 2022

Primary completion

May 15, 2024

Study completion May 15, 2024

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Mar 11, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes that have already been treated with basal insulin. The study consists of a 3-week screening/lead-in period, a 78-week treatment period and a 5-week safety follow-up period. The study will last up to 86 weeks.

Conditions

  • Type 2 Diabetes

Interventions

  • Insulin Efsitora AlfaDrug

    Administered SC

  • Insulin DegludecDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Hemoglobin A1c (HbA1c) [Noninferiority]Time frame: Baseline, Week 26

Locations

127 sites in 10 countries. Site status is shown where the registry gives one.

  • Medical Investigations

    Little Rock, Arkansas

  • John Muir Physician Network Research Center

    Concord, California

  • AMCR Institute

    Escondido, California

  • National Research Institute - Huntington Park

    Huntington Park, California

  • Scripps Whittier Diabetes Institute

    La Jolla, California

  • Diabetes Associates Medical Group

    Orange, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Encore Medical Research

    Hollywood, Florida

  • New Horizon Research Center

    Miami, Florida

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida

  • West Orange Endocrinology

    Ocoee, Florida

  • Balanced Life Health Care Solutions/SKYCRNG

    Lawrenceville, Georgia

  • Rocky Mountain Clinical Research

    Idaho Falls, Idaho

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • L-MARC Research Center

    Louisville, Kentucky

  • Endocrine and Metabolic Consultants

    Rockville, Maryland

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

  • HealthPartners Institute dba International Diabetes Center

    Minneapolis, Minnesota

  • SKY Clinical Research Network Group - Hall

    Fayette, Mississippi

  • Clinvest Research LLC

    Springfield, Missouri

  • Palm Research Center Tenaya

    Las Vegas, Nevada

  • Albany Medical College, Division of Community Endocrinology

    Albany, New York

  • NYC Research

    New York, New York

  • Lillestol Research

    Fargo, North Dakota

  • Aventiv Research Inc

    Columbus, Ohio

  • Intend Research, LLC

    Norman, Oklahoma

  • Heritage Valley Medical Group, Inc.

    Beaver, Pennsylvania

  • Jefferson Clinical Research Institute (JCRI)

    Philadelphia, Pennsylvania

  • Preferred Primary Care Physicians

    Uniontown, Pennsylvania

  • Gadolin Research

    Beaumont, Texas

  • Dallas Diabetes Research Center

    Dallas, Texas

  • Juno Research

    Houston, Texas

  • Biopharma Informatic, LLC

    Houston, Texas

  • Southern Endocrinology Associates

    Mesquite, Texas

  • Texas Diabetes & Endocrinology, P.A.

    Round Rock, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • Rainier Clinical Research Center

    Renton, Washington

  • CEMEDIC

    Buenos Aires, Argentina

  • CENUDIAB

    Ciudad Autónoma de Buenos Aire, Argentina

Showing 40 of 127 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.